Dosimetric adjustments for interspecies extrapolation of inhaled poorly soluble particles (PSP)

Inhalation Toxicology

Volumn 17, Issue 7-8, 2005, Pages 317-334

  Jarabek, Annie M ^a,b   Asgharian, Bahman ^b   Miller, Frederick J ^b  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^b CIIT CENTERS FOR HEALTH RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSIMETRY; FUNCTIONAL RESIDUAL CAPACITY; HUMAN; HUMAN EXPERIMENT; INHALATION; LONG TERM EXPOSURE; LOWER RESPIRATORY TRACT; LUNG MINUTE VOLUME; MACROPHAGE; MALE; MATHEMATICAL MODEL; MUCOCILIARY CLEARANCE; NONHUMAN; NORMAL HUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RAT; RAT STRAIN; RISK ASSESSMENT; SPECIES DIFFERENCE; SPONTANEOUSLY HYPERTENSIVE RAT; TRACHEOBRONCHIAL TREE;

AIR POLLUTANTS; ANIMALS; HUMANS; INHALATION EXPOSURE; MODELS, THEORETICAL; PARTICLE SIZE; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; TOXICITY TESTS;

ANIMALIA;

EID: 21344435496     PISSN: 08958378     EISSN: None     Source Type: Journal    
DOI: 10.1080/08958370590929394     Document Type: Article

References (84)

1. Anjilvel, S., and Asgharian, B. 1995. A multiple-path model of particle deposition in the rat lung. Fundam. Appl. Toxicol. 28:41-50.
2. Asgharian, B. 2004. A model of deposition of hygroscopic particles in the human lung. Aerosol Sci. Technol. 38:938-947.
3. Asgharian, B., Hofmann, W., and Bergmann, R. 2001a. Particle deposition in a multiple-path model of the human lung. Aerosol Sci. Technol. 34:332-339.
4. Asgharian, B., Hofmann, W., and Miller, F. J. 2001b. Mucociliary clearance of insoluble particles from the tracheobronchial airways of the human lung. J. Aerosol Sci. 32:817-832.
5. Asgharian, B., Wong, B. A., Bermudez, E., and Everitt, J. I. 2001c. A model of clearance of titanium dioxide from the rat lung. Toxicologist 60(1):195.
6. Asgharian, B., Kelly, J. T., and Tewksbury, E. W. 2003. Respiratory deposition and inhalability of monodisperse aerosols in Long-Evans rats. Toxicol. Sci. 71:104-111.
7. Asgharian, B., Ménache, M. G., and Miller, F. J. 2004. Modeling age-related particle deposition in humans. J. Aerosol Med. 17(3):213-224.
8. Bailey, M. R., Ansoborlo, E., Guilmette, R. A., and Paquet, F. 2003a. Practical applications of the ICRP human respiratory tract model. Radiat. Protect. Dosim. 105(1-4):71-76.
9. Bailey, M. R., Ansoborlo, E., Camner, P., Chazel, V., Fritsch, P., Hodgson, A., Kreyling, W. G., Le Gall, B., Newton, D., Paquet, F, Stradling, N., and Taylor, D. M. 2003b. RBDATA-EULEP: Providing information to improve internal dosimetry. Radiat. Protect. Dosim. 105(1-4):633-636.
10. Bermudez, E., Mangum, J. B., Asgharian, B., Wong, B. A., Reverdy, E. E., Janszen, D. B., Hext, P M., Warheit, D. B., and Everitt, J. I. 2002. Long-term pulmonary responses of three laboratory rodent species to subchronic inhalation of pigmentary titanium dioxide particles. Toxicol. Sci. 70:86-97
11. Bogdanffy, M. S., and Jarabek, A. M. 1995. Understanding mechanisms of inhaled toxicants: implications for replacing default factors with chemical-specific data. Toxicol. Lett. 82/83:919-932.
12. Bogdanffy, M. S., Daston, G., Faustman, E. M., Kimmel, C. A., Kimmel, G. L., Seed, J., and Vu, V. 2001. Harmonization of cancer and noncancer risk assessment: Proceedings of a consensus-building workshop Toxicol. Sci. 61:18-31.
13. Cassee, F. R., Muijser, H., Duistermaat, E., Freijer, J. J., Geerse, K. B., Marijnissen, J. C. M., and Arts, J. H. E. 2002. Particle-size dependent total mass deposition in lungs determines inhalation toxicity of cadmium chloride aerosols in rats. Application of a multiple path dosimetry model. Arch. Toxicol. 76:277-286.
14. CIIT Centers for Health Research. 2004. Multiple path particle dosimetry model MPPD, v. 2.0.
15. Clarke, R. W., Catalano, P. J., Koutrakis, P., Krishna, M. G. G., Sioutas, C., Paulauskis, J., Coull, B., Ferguson, S., and Godleski, J. J. 1999. Urban air particulate inhalation alters pulmonary function and induces pulmonary inflammation in a rodent model of chronic bronchitis. Inhal. Toxicol. 11:637-656.
16. Clewell, H. J., Gentry, P. R., Covington, T. R., Sarangapani, R., and Teeguarden, J. G. 2004. Evaluation of the potential impact of age- and gender-specific pharmacokinetic differences on tissue dosimetry. Toxicol. Sci. 79:381-393.
17. Conolly, R. B., Kimbell, J. S., Janszen, D., Schlosser, P. M., Kalisak, D., Preston, J., and Miller, F. J. 2003. Biologically-motivated computational modeling of formaldehyde carcinogenicity in the F344 rat. Toxicol. Sci. 75:432-447.
18. Conolly, R. B., Kimbell, J. S., Janszen, D., Schlosser, P. M., Kalisak, D., Preston, J., and Miller, F. J. 2004. Human respiratory tract cancer risks of inhaled formaldehyde: Dose-response predictions derived from biologically-motivated computational modeling of a combined rodent and human dataset. Toxicol. Sci. 8:1-18.
19. Dahl, A. R., Schlesinger, R. B., Heck, H.d' A., Medinsky, M. A., and Lucier, G. W. 1991. Comparative dosimetry of inhaled materials: Differences among animal species and extrapolation to man. Fundam. Appl. Toxicol. 16:1-13.
20. DeLorme, M. P., and Moss, O. R. 2002. Comparison of restrained and unrestrained whole-body plethysmographs for mice. J. Pharmacol. Toxicol. Methods 47:1-10.
21. Dormans, J. A. M. A., Steerenberg, P. A., Arts., J. H. E., Van Bree, L., De Klerk, A., Verlann, A. P. J., Bruijntjes, J. P., Beekhof, P., Van Soolingen, D., and Van Loveren, H. 1999. Pathological and immunological effects of respirable coal fly ash in male Wistar rats. Inhal. Toxicol. 11:51-69.
22. Driscoll, K. E., Deyo, L. C., Carter, J. M., Howard, B. W., Hassenbein, D. G., and Bertram, T. A. 1997. Effects of particule exposure and particle-elicited inflammatory cells on mutation in rat alveolar type II cells. Carcinogenesis 18:23-430.
23. Duffin, R., Tran, C. L., Clouter, A., Brown, D. M., MacNee, W., Stone, V., and Dondaldson, K. 2002. The importance of surface area and specific reactivity in the acute pulmonary inflammatory response to particles. Ann. Occup. Hyg. 46(suppl.1):242-245.
24. Ohio, A. J., Kim, C., and Devlin, R. B. 2000. Concentrated ambient air particles induce mild pulmonary inflammation in healthy human volunteers. Am. J. Respir. Crit. Care Med. 162:981-988.
25. Gong, H., Sioutas, C., Linn, W. S., Clark, K. W., Terrell, S. L., Terrell, L. L., Anderson, K. R., Kim, S., and Chang, M.-C. 2000. Controlled human exposures to concentrated ambient fine particles in metropolitan Los Angeles: Methodology and preliminary health-effect findings. Inhal. Toxicol. 12(suppl. 1): 107-119.
26. Greim, H., Borm, P., Schins, R., Donaldson, K., Driscoll, K., Hartwig, A., Kuempel, E., Oberdörster, G., and Speit, G. 2001. Toxicity of fibers and particles-Report of the workshop held in Munich, Germany, 26-27 October 2000. Inhal. Toxicol. 13(9):737-754.
27. Haber, F. 1924. Zur geschichte des gaskrieges (On the history of gas warfare). In Fünf Vorträge aus den Jahren 1920-1923 (Five lectures from years 1920-1923), pp. 76-92. Berlin: Springer.
28. Hatch, T., and Choate, S. P. 1929. Statistical description of the size properties of non-uniform particulate substances. J. Franklin Inst. 207:369-387.
29. Heyder, J., Beek-Speier, I., Busch, B., Dirscherl, P., Heilmann, P., Ferron, G. A., Josten, M., Karg, E., Kreyling, W. G., Lenz, A.-G., Maier, K. L., Miaskowski, U., Platz, S., Reitmeir, P., Schulz, H., Takenaka, S., and Ziesenis, A. 1999. Health effects of sulfur-related environmental air pollution. I. Executive summary. Inhal. Toxicol. 11:343-359.
30. Hofmann, W., and Bergmann, R. 1998. Predictions of particle deposition patterns in human and rat airways. Inhal. Toxicol. 10:557-583.
31. Hofmann, W., and Koblinger, L. 1989. The effect of polydispersity of radioactive aerosols on the activity distribution in the human lung. J. Aerosol. Sci. 20:1313-1316.
32. International Commission on Radiological Protection. 1994. Human respiratory tract model for radiological protection. ICRP Publication 66. Annals ICRP 24:1-3.
33. International Life Sciences Institute. 2000. ILSI Risk Science Institute Workshop: The relevance of the rat lung response to particle overload for human risk assessment: A workshop consensus resport. Inhal. Toxicol. 12(1-2):1-17.
34. Iarabek, A. M. 1994. Inhalation RfC methodology: dosimetric adjustments and dose-response estimation of noncancer toxicity in the upper respiratory tract. Inhal. Toxicol. 6(suppl. 1):301-325.
35. Jarabek, A. M. 1995a. Interspecies extrapolation based on mechanistic determinants of chemical disposition. Hum. Ecol. Risk Assess. 1(5):641-662.
36. Jarabek, A. M. 1995b. Consideration of temporal toxicity challenges current default approaches. Inhal. Toxicol. 7:929-946.
37. Jarabek, A. M. 1995c. The application of dosimetry models to identify key processes and parameters for default dose-response assessment approaches. Toxicol. Lett. 79:171-184.
38. Jarabek, A. M. 2000. Mode of action: Framework for dosimetry model development. Presented at Mode-of-Action Dosimetry: An Interagency Project to Develop Models for Inhalation, Oral, and Dermal Disposition, Annual Meeting of the Society for Risk Analysis, 4-6 December, Arlington, VA. Abstract available online at http://www.sra.org.
39. Jarabek, A. M., Ménache, M. G., Overton, J. H., Jr., Dourson, M. L., and Miller, F. J. 1989. Inhalation reference Dose (RfDi): An application of interspecies dosimetry modeling for risk assessment of insoluble particles. Health. Phys. 57(suppl. 1):177-183.
40. Jarabek, A. M., Ménache, M. G., Overton, J. H., Jr., Dourson, M. L., and Miller, F. J. 1990. The U.S. Environmental Protection Agency's inhalation RfD methodology: Risk assessment for air toxics. Toxicol. Ind. Health 6:279-301.
41. Killingsworth, C. R., Alessandrini, F., Krishna Murthy, G. G., Catalano, P. J., Paulauskis, J. D., and Godleski, J. J. 1997. Inflammation, chemokine expression, and death in monocrotaline-treated rats following fuel oil fly ash inhalation. Inhal. Toxicol. 9:541-565.
42. Kimbell, J. S., Subramaniam, R. P., Gross, E. A., Schlosser, P. M., and Morgan, K. T. 2001. Dosimetry modeling of inhaled formaldehyde: Comparisons of local flux predictions in the rat, monkey, and human nasal passages. Toxicol. Sci. 64:100-110.
43. Kimbell, J. S., Kalisak, D. L., Conolly, R. B., Miller, F. J., and Jarabek, A. M. 2004. A mechanistic model of lifetime cancer risk for inhalation exposures to reactive gases. Toxicol. Sci.
44. Koblinger, L., and Hofmann, W. 1985. Analysis of human lung morphometric data for stochastic aerosol deposition calculations. Phys. Med. Biol. 30:541-556.
45. Koblinger, L., and Hofmann, W. 1990. Monte Carlo modeling of aerosol deposition in human lungs. Part I: Simulation of particle transport in a stochastic lung structure. J. Aerosol Sci. 21:661-674.
46. Kodavanti, U. P., Schladweiler, M. C., Ledbetter, A. D., Watkinson, W. P., Campen, M. J., Winsett, D. W., Richards, J. R., Crissman, K. M., Hatch, G. E., and Costa, D. L. 2000. The spontaneously hypertensive rat as a model of human cardiovascular disease: Evidence of exacerbated cardiopulmonary injury and oxidative stress from inhaled emission particulate matter. Toxicol. Appl. Pharmacol. 164:250-263.
47. Ménache, M. G., Miller, F. J., and Raabe, O. G. 1995. Particle inhalability curves for humans and small laboratory animals. Ann. Occup. Hyg. 39(3):317-328.
48. Miller, F. J. 2000. Dosimetry of particles in laboratory animals and humans in relationship to issues surrounding lung overload and human health risk assessment: A critical review. Inhal. Toxicol. 12(1-2):19-58.
49. Miller, F. J., Martonen, T. B., Ménache, M. G., Graham, R. C., Spektor, D. M., and Lippmann, M. 1988. Influence of breathing mode and activity level on the regional deposition of inhaled particles and implications for regulatory standards. In Inhaled particles VI: Proceedings of an international symposium and workshop on lung dosimetry eds. J. Dodgson, R. I. McCallum, M. R. Bailey, and D. R. Fisher, September 1985, Cambridge, United Kingdom.
50. Ann. Occup. Hyg. 32(suppl. 1):3-10.
51. Miller, F. J., Anjilvel, S., Ménache, M. G., Asgharian, B., and Gerrity, T. R. 1995. Dosimetric issues relating to particulate toxicity. In Proceedings of the colloquium on particulate air pollution and human mortality and morbidity, Part II, eds. R. F. Phalen and D. V. Bates, January 1994, Irvine, CA.
52. Inhal. Toxicol. 7:615-632.
53. Miller, F. J., Schlosser, P. M., and Jansen, D. B. 2000. Haber's rule: A special case in a family of curves relating concentration and duration of exposure to a fixed level of response for a given endpoint. Toxicologist 149:21-34.
54. Morrow, P. E. 1988. Possible mechanisms to explain dust overloading of the lungs. Fundam. Appl. Toxicol. 10:369-384.
55. Moss, O. R., and Cheng, Y.-S. 1989. Generation and characterization of test atmospheres: Particles. In Concepts in inhalation toxicology, eds. R. O. McClellan and R. F. Henderson, pp. 85-120. New York: Hemisphere.
56. National Council on Radiation Protection and Measurements. 1997. Deposition, retention and dosimetry of inhaled radioactive substances. NCRP Report 125. Bethesda, MD: NCRP.
57. Oberdörster, G. 1996. Significance of particle parameters in the evaluation of exposure-dose-response relationships of inhaled particles. In Particle overload in the rat lung and lung cancer: Implications for human risk assessment, eds. J. L. Mauderley and R. J. McCunney, Proceedings of a conference held at the Massachusetts Institute of Technology, 29-30 March 1995, pp. 73-90. Washington DC: Taylor & Francis.
58. Oberdörster, G. 2002. Toxicokinetics and effects of fibrous and nonfibrous particles. Inhal. Toxicol. 14(1):29-56.
59. Oberdörster, G., Ferin, J., and Lehnen, B. E. 1994. Correlation between particle size, in vivo particle persistence, and lung injury. Environ. Health Perspect. 102(suppl. 5):173-179.
60. Raabe, O. G., Yeh, H.-C., Schum, G. M., and Phalen, R. F. 1976. Tracheobronchial geometry: Human, dog, rat, hamster. Albuquerque, NM: Lovelace Foundation, Report LF-53.
61. Raabe, O. G., Yeh, H.-C., Newton, G. J., Phalen, R. F., and Velasquez, D. J. 1977. Deposition of inhaled monodisperse aerosols in small rodents. In Inhaled particles IV, Part I: Proceedings of an international symposium, eds. W. H. Walton, and B. McGovern, September 1975, Edinburgh, Scotland, pp. 3-21. Oxford, U.K: Pergamon Press.
62. Raabe, O. G., Al-Bayati, M. A., league, S. V., Rasolt, A. 1988. Regional deposition of inhaled monodisperse, coarse, and fine aerosol particles in small laboratory animals. In inhaled particles VI: Proceedings of an international symposium and workshop on lung dosimetry, eds. J. Dodgson, R. I. McCallum, M. R. Bailey, and D. R. Fischer, September, 1985, Cambridge, United Kingdom.
63. Ann. Occup. Hyg. 32(suppl. 1):53-63.
64. Rudolf, G. 1984. A mathematical model for the deposition of aerosol particles in the human respiratory tract. J. Aerosol Sci. 15:195-199.
65. Schlesinger, R. B. 1985. Comparative deposition of inhaled aerosols in experimental animals and humans: A review. J. Toxicol. Environ. Health 15:197-214.
66. Schroeter, J. D., Musante, C. J., Hwang, D., Burton, R., Guilmette, R., and Martonen, T. B. 2001. Hygroscopic growth and deposition of inhaled secondary cigarette smoke in human nasal pathways. Aerosol Sci. Technol. 34:137-143.
67. Segal, R. A., Martonen, T. B., Kim, C. S., and Shearer, M. 2002. Computer simulations of particle deposition in the lungs of chronic obstructive pulmonary disease patients. Inhal. Toxicol. 14:705-720.
68. Snipes, M. B., James, A. C., and Jarabek, A. M. 1997. The 1994 ICRP66 human respiratory tract model as a tool for predicting lung burdens from exposures to environmental aerosols. Appl. Occup. Environ. Hyg. 12(8):547-554.
69. Stöber, W., Morrow, P. E., Koch, W., and Morawietz, G. 1994. Alveolar clearance and retention of inhaled insoluble particles in rats simulated by a model inferring macrophage particle load distributions. J. Aerosol Sci. 25(5):975-1002.
70. Stone, K. C., Mercer, R. R., Gehr, P., Stockstill, B., and Crapo, J. D. 1992. Allometric relationships of cell numbers and size in the mammalian lung. Am. J. Respir. Cell. Mol. Biol. 6:235-243.
71. Subramaniam, R. P., Asgharian, B., Freijer J. I., Miller, F. J., and Anjilvel, S. 2003. Analysis of lobar differences in particle deposition in the human lung. Inhal. Toxicol. 15(1):1-21.
72. Tran, C. L., Buchanan, D., Cullen, R. T., Searl, A., Ones, A. D., and Donaldson, K. 2000a. Inhalation of poorly soluble particles. II. Influence of particle surface area on inflammation and clearance. Inhal. Toxicol. 12:1113-1126.
73. Tran, C. L., Buchanan, D., Miller, B. G., and Jones, A. D. 2000b. Mathematical modeling to predict the response to poorly soluble particles in rat lungs. Inhal. Toxicol. 12(3):403-409.
74. U.S. Environmental Protection Agency. 1994. Methods for derivation of inhalation reference concentrations and application of inhalation dosimetry. Office of Research and Development, Office of Health and Environmental Assessment, Environmental Criteria and Assessment Office, Research Triangle Park, NC. Report EPA/600/8-90/066F. Final. October.
75. U.S. Environmental Protection Agency. 1995. The use of the benchmark dose in health risk assessment. Office of Research and Development, Risk Assessment Forum, Washington, DC. EPA/630/R-94/007.
76. U.S. Environmental Protection Agency. 1996. Dosimetry of inhaled particles in the respiratory tract In Air quality criteria for particulate matter, vol. II of III, chap. 10. Office of Research and Development, Washington, DC. EPA/600/P-95/001bF. April.
77. U.S. Environmental Protection Agency. 1999. Revised cancer guidelines for carcinogen risk assessment. Office of Research and Development, Risk Assessment Forum. NCEA_F-0644. External review draft.
78. U.S. Environmental Protection Agency. 2004. Dosimetry of particulate matter. In Air quality criteria for particulate matter, vol II of II, chap. 6. Office of Research and Development, Washington, DC. EPA 600P-99/002bF.
79. Wiltse, J. A., and Dellarco, V. L. 2000. U.S. Environmental Protection Agency's revised guidelines for carcinogen risk assessment: Evaluating a postulated mode of carcinogenic action in guiding dose-response extrapolation. Mutat. Res. 464:105-115.
80. Wolff, R. K. 1992. Mucociliary function. In Treatise on pulmonary toxicology: Comparative biology of the normal lung, vol. I, ed. R. A. Parent, chap, 35. Boca Raton, FL: CRC Press.
81. Yeh, H.-C., and Schum, G. M. 1980. Models of human lung airways and their application to inhaled particle deposition. Bull. Math. Biol. 42:461-480.
82. Yeh, H.-C., Schum, G. M., and Duggen, M. T. 1979. Anatomic models of the tracheobronchial and pulmonary regions of the rat. Anat. Rec. 195:483-492.
83. Yu, C. P. 1996. Extrapolation modeling of particle deposition and retention from rats to humans. Inhal. Toxicol. 8(suppl.):279-291.
84. Zhang, L., and Yu, C. P. 1993. Empirical equations for nasal deposition of inhaled particles in small laboratory animals and humans. Aerosol Sci. Technol. 19:51-56.